TY  - JOUR
AU  - Olma, Manuel C
AU  - Steindorf-Sabath, Lena
AU  - Tütüncü, Serdar
AU  - Kunze, Claudia
AU  - Fiessler, Cornelia
AU  - Kirchhof, Paulus
AU  - Dietzel, Joanna
AU  - Schurig, Johannes
AU  - Oschmann, Patrick
AU  - Niehaus, Ludwig
AU  - Urbanek, Christian
AU  - Thomalla, Götz
AU  - Nabavi, Darius G
AU  - Röther, Joachim
AU  - Laufs, Ulrich
AU  - Veltkamp, Roland
AU  - Heuschmann, Peter U
AU  - Haeusler, Karl Georg
AU  - Endres, Matthias
TI  - The Role of Atrial Fibrillation and Oral Anticoagulation Status in Health-Related Quality of Life 12 Months After Ischemic Stroke or TIA.
JO  - Brain and behavior
VL  - 15
IS  - 1
SN  - 2162-3279
CY  - Malden, Mass.
PB  - Wiley
M1  - DZNE-2025-00111
SP  - e70248
PY  - 2025
AB  - Atrial fibrillation (AF) accounts for about 20
KW  - Humans
KW  - Atrial Fibrillation: drug therapy
KW  - Atrial Fibrillation: physiopathology
KW  - Atrial Fibrillation: complications
KW  - Quality of Life
KW  - Female
KW  - Male
KW  - Anticoagulants: administration & dosage
KW  - Aged
KW  - Ischemic Stroke: physiopathology
KW  - Ischemic Attack, Transient: physiopathology
KW  - Middle Aged
KW  - Prospective Studies
KW  - Aged, 80 and over
KW  - Administration, Oral
KW  - Severity of Illness Index
KW  - atrial fibrillation (Other)
KW  - ischemic stroke (Other)
KW  - oral anticoagulation (Other)
KW  - quality of life (Other)
KW  - transient ischemic attack (Other)
KW  - Anticoagulants (NLM Chemicals)
LB  - PUB:(DE-HGF)16
C6  - pmid:39779216
C2  - pmc:PMC11710889
DO  - DOI:10.1002/brb3.70248
UR  - https://pub.dzne.de/record/275876
ER  -